EFTR Annual CFI
$14.48 M
+$32.34 M+181.10%
31 December 2023
Summary:
As of January 22, 2025, EFTR annual cash flow from investing activities is $14.48 million, with the most recent change of +$32.34 million (+181.10%) on December 31, 2023. During the last 3 years, it has risen by +$14.64 million (+9505.19%). EFTR annual CFI is now at all-time high.EFTR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EFTR Quarterly CFI
-$6.32 M
-$15.27 M-170.66%
31 March 2024
Summary:
As of January 22, 2025, EFTR quarterly cash flow from investing activities is -$6.32 million, with the most recent change of -$15.27 million (-170.66%) on March 31, 2024. Over the past year, it has dropped by -$15.35 million (-170.02%). EFTR quarterly CFI is now -170.02% below its all-time high of $9.03 million, reached on March 31, 2023.EFTR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EFTR TTM CFI
-$864.00 K
-$15.35 M-105.97%
31 March 2024
Summary:
As of January 22, 2025, EFTR TTM cash flow from investing activities is -$864.00 thousand, with the most recent change of -$15.35 million (-105.97%) on March 31, 2024. Over the past year, it has dropped by -$20.30 million (-104.44%). EFTR TTM CFI is now -104.44% below its all-time high of $19.44 million, reached on March 31, 2023.EFTR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EFTR Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +181.1% | -170.0% | -104.4% |
| 3 y3 years | +9505.2% | -170.0% | -104.4% |
| 5 y5 years | +9505.2% | -170.0% | -104.4% |
EFTR Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +181.1% | -170.0% | +77.6% | -104.4% | +97.0% |
| 5 y | 5-year | at high | +181.1% | -170.0% | +77.6% | -104.4% | +97.0% |
| alltime | all time | at high | +181.1% | -170.0% | +77.6% | -104.4% | +97.0% |
EFFECTOR Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$6.32 M(-170.7%) | -$864.00 K(-106.0%) |
| Dec 2023 | $14.48 M(-181.1%) | $8.95 M(-567.2%) | $14.48 M(+58.1%) |
| Sept 2023 | - | -$1.92 M(+21.7%) | $9.16 M(-37.7%) |
| June 2023 | - | -$1.57 M(-117.4%) | $14.70 M(-24.4%) |
| Mar 2023 | - | $9.03 M(+149.2%) | $19.44 M(-208.9%) |
| Dec 2022 | -$17.86 M | $3.62 M(-0.0%) | -$17.86 M(-17.0%) |
| Sept 2022 | - | $3.62 M(+14.3%) | -$21.52 M(-14.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $3.17 M(-111.2%) | -$25.15 M(-11.2%) |
| Mar 2022 | - | -$28.27 M(>+9900.0%) | -$28.32 M(-5111.7%) |
| Dec 2021 | $565.00 K(-466.9%) | -$36.00 K(+500.0%) | $565.00 K(-6.0%) |
| Sept 2021 | - | -$6000.00(<-9900.0%) | $601.00 K(-1.0%) |
| June 2021 | - | $0.00(-100.0%) | $607.00 K(0.0%) |
| Mar 2021 | - | $607.00 K | $607.00 K |
| Dec 2020 | -$154.00 K | - | - |
FAQ
- What is eFFECTOR Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual CFI year-on-year change?
- What is eFFECTOR Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly CFI year-on-year change?
- What is eFFECTOR Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics TTM CFI year-on-year change?
What is eFFECTOR Therapeutics annual cash flow from investing activities?
The current annual CFI of EFTR is $14.48 M
What is the all time high annual CFI for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual cash flow from investing activities is $14.48 M
What is eFFECTOR Therapeutics annual CFI year-on-year change?
Over the past year, EFTR annual cash flow from investing activities has changed by +$32.34 M (+181.10%)
What is eFFECTOR Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of EFTR is -$6.32 M
What is the all time high quarterly CFI for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly cash flow from investing activities is $9.03 M
What is eFFECTOR Therapeutics quarterly CFI year-on-year change?
Over the past year, EFTR quarterly cash flow from investing activities has changed by -$15.35 M (-170.02%)
What is eFFECTOR Therapeutics TTM cash flow from investing activities?
The current TTM CFI of EFTR is -$864.00 K
What is the all time high TTM CFI for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high TTM cash flow from investing activities is $19.44 M
What is eFFECTOR Therapeutics TTM CFI year-on-year change?
Over the past year, EFTR TTM cash flow from investing activities has changed by -$20.30 M (-104.44%)